Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

After reaching an important support level, Intuitive Surgical, Inc. (ISRG) could be a good stock pick from a technical perspective. ISRG surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.

Intuitive Surgical, Inc. (ISRG) Just Reclaimed the 50-Day Moving Average

Intuitive Surgical (NASDAQ: ISRG) recently reported its Q2 results, with revenues matching and earnings exceeding our estimates. The company reported revenue of $2.0 billion and adjusted earnings of $1.78 per share, compared to our estimates of $2.0 billion and $1.55, respectively.

Up 35% This Year, Will The Solid Q2 Performance Help Intuitive Surgical Stock Extend Its Winning Streak?

Vertex Pharmaceuticals

Exxon Mobil

U.S. M2 money supply has done something that no one has witnessed since the Great Depression. Meanwhile, the benchmark S&P 500 is at one of its priciest valuations in history.

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street

Coinbase

Garmin

Progressive

Urban Outfitters

Coinbase jumped Friday as bitcoin spiked. Urban Outfitters, Progressive also are stocks near buy points.

Coinbase Flashes Buy Signal On Bitcoin Rally, Leads 5 Stocks To Watch

Intuitive Surgical (ISRG) shares traded at an all-time high Friday after the maker of robotic medical devices posted better-than-expected second-quarter results on soaring demand for its da Vinci surgical machine.

Intuitive Surgical Stock Hits Record High as Demand for Its Robotic Devices Surges

Intuitive Surgical Inc. ISRG stock is trading higher on Friday after the robotic-assisted surgery company reported second-quarter earnings that were better than expected.

Intuitive Surgical's Resilience Amid Multiple Headwinds, Analyst Predicts Strong Momentum

Intuitive Surgical's (ISRG) second-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales.

Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust

Costco

First Solar

Interactive Brokers

Texas Roadhouse

We have narrowed our search to five Nasdaq Composite-listed non-tech stocks. These are: COST, ISRG, IBKR, TXRH, FSLR.

5 Non-Tech Nasdaq Stocks to Buy Amid Index's Recent Bloodbath

Medtronic

Rockwell Automation

Automation advancements have been incredible, putting the spotlight on the robotics sector as a whole. Indeed, the rise of artificial intelligence has boosted robotics use in manufacturing, healthcare, and e-commerce.

If You Can Only Buy One Robotics Stock in July, It Better Be One of These 3 Names

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q2 2024 Earnings Conference Call July 18, 2024 4:30 PM ET Company Participants Brian King - Head of IR Gary Guthart - CEO Dave Rosa - President Jamie Samath - CFO Conference Call Participants Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Robbie Marcus - JPMorgan David Roman - Goldman Sachs Rick Wise - Stifel Drew Ranieri - Morgan Stanley Adam Maeder - Piper Sandler Richard Newitter - Truist Securities Operator Thank you everyone for standing by and welcome to the Intuitive Second Quarter 2024 Earnings Release. [Operator Instructions] As a reminder, today's call is being recorded.

Intuitive Surgical, Inc. (ISRG) Q2 2024 Earnings Call Transcript

Netflix

Year-to-date, the Nasdaq is still +20%, the S&P +16%, the Russell +9% and the Dow +7.5%.

Markets Book Profits; Netflix, Intuitive Beat Estimates in Q2

While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.42 per share a year ago.

Intuitive Surgical, Inc. (ISRG) Tops Q2 Earnings and Revenue Estimates

Intuitive Surgical stock jumped late Thursday after the robotics behemoth smashed Wall Street's second-quarter earnings forecasts.

Intuitive Surgical Surges After Robotics Giant Blows Profit Forecasts Out Of The Water

Intuitive Surgical on Thursday beat estimates for second-quarter profit and revenue on growing demand for its surgical robots used in minimally invasive procedures, sending its shares up 6.7% after the bell.

Intuitive Surgical results beat on growing demand for surgical robots

SUNNYVALE, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2024.

Intuitive Announces Second Quarter Earnings

Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.

Intuitive Surgical (ISRG) Gains 26% Year to Date: Here's Why

Intuitive Surgical (NASDAQ: ISRG ) stock is on the move Thursday after the company's shares were given a price target increase by Barclays analysts. Barclays analyst Matt Miksic increased the firm's price target for ISRG stock from $430 per share to $490 per share.

Barclays Just Raised Its Price Target on Intuitive Surgical (ISRG) Stock

Arbe Robotics Ltd

Samsara

Humans have enjoyed the fruits of automation for a long time, at least since the Industrial Revolution in the late 18th century. We are now entering a more complex age that relies on both smarter machines and the management of data, making it an opportune time to consider robotics stocks to buy now.

3 Robotics Stocks to Buy Now: Q3 Edition

Intuitive Surgical (NASDAQ: ISRG) will report its Q2 2024 results on Thursday, July 18. We expect the company's revenues to come in at $2 billion and adjusted earnings to be $1.55 per share, broadly aligning with the consensus estimate.

Da Vinci 5 In Focus As Intuitive Surgical Reports Its Q2

The Intuitive Surgical (NASDAQ: ISRG) stock price is hovering near its all-time highest point on record as investors focus on its upcoming quarterly earnings. It has soared by 30% this year and by over 735% in the past decade, making it one of the most successful medical device companies in Wall Street.

Intuitive Surgical: ISRG stock is expensive and extremely risky

Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

How to Play Intuitive Surgical (ISRG) Ahead of Q2 Earnings?

Alcon Inc. - Registered Shares

DexCom

Hologic

Thermo Fisher Scientific

DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.

The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

Intuitive Surgical's revenue and EPS for Q1 beat estimates, and the stock has risen 17% since the last earnings preview. The release of the da Vinci 5 robotic system is expected to boost sales by encouraging upgrades among current users. Analysts expect Q2 EPS of $1.54 and revenue of $1.97 billion, with a focus on procedure growth and new system placements.

Intuitive Surgical Q2 Earnings Preview: Near-Term Volatility, Long-Term Growth

We have narrowed our search to five Medical Instruments stocks. These are: DXCM, TMO, ISRG, ALC, HOLX.

News for Intuitive Surgical Stock (ISRG)